Nonetheless, cfDNA, miR-106b-5p, miR-124, miR-155, and lncRNA H19 emerge as the most promising AIS diagnostic markers in high-quality studies, suggesting that future prospective research could focus on validating these markers. This evidence concerns the gene H19 and androgen insensitivity syndrome.